Amanta Healthcare Limited has informed the Exchange about Amendment to the code
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare Limited reported strong financial results for FY2026 ended March 31, 2026. Revenue from operations grew 4.7% to Rs 28,768 lakhs from Rs 27,471 lakhs in FY2025. Profit after tax surged 41.7% to Rs 1,488 lakhs from Rs 1,050 lakhs, driven by higher other income (Rs 337 vs Rs 139 lakhs) and lower finance costs. EPS improved to Rs 4.33 from Rs 3.71. The company also completed its IPO in September 2025 raising Rs 12,600 lakhs, with Rs 5,247 lakhs still unutilized as deployment was delayed due to pending supplier milestones and commercial term finalizations. The Board approved amendments to the Code of Conduct for Prevention of Insider Trading and Whistle Blower Policy. Statutory auditors Price Waterhouse Chartered Accountants LLP issued an unmodified opinion.
Strong profit growth and improved EPS indicate healthy operational performance. The substantial IPO proceeds and improved cash position (Rs 8,101 lakhs vs Rs 22 lakhs) provide firepower for expansion. Delayed IPO fund utilization may raise questions on execution timelines.